Michelle Bradbury, M.D., Ph.D.
Dr. Bradbury is a co-founder of Elucida Oncology and co-inventor of the company's core intellectual property. Dr. Bradbury is a Professor of Radiology at MSKCC and Co-Director of the MSKCC-Cornell Center for Translation of Cancer Nanomedicines (MC2TCN), a Center of Cancer Nanotechnology Excellence (CCNE) funded by the National Cancer Institute (NCI). She is also the Director of the Intraoperative Imaging Program, Co-Chair of the Innovations and Technology Team, and a Member of the Molecular Pharmacology Program. Dr. Bradbury specializes in nanomedicine and molecular imaging/radiological sciences, and led the successful clinical translation of C-Dots. Dr. Bradbury has amassed an impressive array of patents, publications, and research grants, in addition to receiving numerous recognitions. She is an active leader in the nanotechnology community, and has been named to several national and international nanomedicine boards.